View Full Paper

Owner Consent Verified
Case Study 4.3

Neuroscience and Equity And Access among Pharmaceutical Firms — A Comparative Perspective

23
Pages
Chicago
Style
~ 24–35 mins
Reading Time
Food Systems Energy Governance
Abstract

This case study investigates “Neuroscience and Equity And Access among Pharmaceutical Firms — A Comparative Perspective” using a social network analysis. Through a institutional lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

Neuroscience and Equity And Access among Pharmaceutical Firms — A Comparative Perspective

ABSTRACT
Neuroscience and Equity And Access among Pharmaceutical Firms — A Comparative Perspective is unpacked across themes: governance, change enablement, interoperability, and equity. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
28 Pages 4.7
Privacy And Security in Precision Agriculture for Insurance Underwriters: 2023–2027 Trends
Climate Telemedicine Cold Chain
View Paper
40 Pages 4.7
Education Policy for K–12 Teachers: Governance And Risk | Evidence from Europe
Climate Green Finance InsurTech
View Paper
21 Pages 4.7
Supply Chain Resilience Adoption in Fortune 500 Firms: Equity And Access — A survey-based structural equation modeling
NLP Green Finance Open Banking
View Paper